Home Sleep Apnea Testing Devices Market (Fisher & Paykel Healthcare, ImThera Medical, Inc., Natus Medical, Inc., Somnetics International, Inc., Braebon Medical Corporation, BMC Medical Co., Ltd., Teleflex, Inc., Weinmann Medical Devices GmbH & Co., KG., Philips Respironics, CareFusion Corp., Compumedics Limited, and Nihon Kohden., and Others.) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global home sleep apnea testing devices market size was USD 1,037.34 million in 2023, calculated at USD 1,211.93 million in 2024 and is expected to reach around USD 4,914.35 million by 2033. The market is expanding at a solid CAGR of 16.83% over the forecast period 2024 to 2033. The rising prevalence of chronic conditions such as heart disease among patients with sleep disorders is driving the demand for the home sleep apnea test devices market.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. home sleep apnea testing devices market size was calculated at USD 264.52 million in 2023 and is projected to attain around USD 1,280.07 million by 2033, poised to grow at a CAGR of 17.07% from 2024 to 2033.
North America dominated the global home sleep apnea test devices market in 2023. North America plays a significant role in the global market for home sleep apnea test devices, with major contributions from the United States and Canada. The region benefits from a robust economy, technological advancements, and a strong consumer base with high purchasing power. The substantial growth in North America is attributed to its developed healthcare infrastructure. The United States and Canada host many leading companies in the home sleep apnea test devices market with their advanced healthcare systems.
Asia Pacific is projected to experience the fastest growth in the home sleep apnea test devices market during the forecast period. This growth is being driven by countries such as China, Japan, India, and South Korea. This growth is supported by a large population, rising disposable incomes, and increasing urbanization, which can collectively boost the demand for the home sleep apnea test devices market and related services.
The home sleep apnea test devices market in India may expand or contract due to various factors, including macroeconomic conditions, population demographics, disease incidence rates, and geopolitical factors. Disruptions in the market can occur due to sudden and unexpected changes in these factors, as well as changes in clinical practices that influence the diagnosis and treatment of patients, as part of ongoing efforts to improve medical practices in general.
Sleep apnea is a sleep disorder that can lead to severe health issues such as hypertension, diabetes, stroke, cardiomyopathy, heart failure, and heart attacks. Untreated sleep apnea causes repeated breathing interruptions during sleep, resulting in loud snoring and daytime fatigue, even after a full night's rest. While it can affect anyone, it is most common in older, overweight men. However, it also affects people of all ages, including infants and children, particularly those over 50 and those who are overweight.
Common physical characteristics in patients with obstructive sleep apnea include excessive weight, a large neck, and structural abnormalities that narrow the upper airway, such as nasal obstruction, a low-hanging soft palate, enlarged tonsils, or a small jaw with an overbite. Sleep apnea is typically caused by a blockage of the airway when the soft tissue at the back of the throat collapses during sleep. Diagnosis involves sleep tests such as an overnight sleep study called a polysomnogram (PSG) or a home sleep test (HST).
Report Coverage | Details |
Home Sleep Apnea Testing Devices Market Size in 2023 | USD 1,037.34 Million |
Home Sleep Apnea Testing Devices Market Size in 2024 | USD 1,211.93 Million |
Home Sleep Apnea Testing Devices Market Size by 2033 | USD 4,914.35 Million |
Home Sleep Apnea Testing Devices Market Growth Rate | CAGR of 16.83% from 2024 to 2033 |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Rising demand for home sleep apnea testing
In the home sleep apnea test devices market, the demand for home sleep apnea testing remains high, as it provides physicians with comprehensive information about a patient's breathing patterns. However, recent regulations from regional regulatory bodies for manufacturing sleep apnea devices have made it more challenging for new home sleep apnea testing manufacturers to enter the market.
Various home sleep apnea testing devices equipped with advanced sensors and detectors are available and are driving the home sleep apnea test devices market. These diagnostic tools often measure heart rate and oxygen levels, and their diverse applications are expanding the market for home sleep apnea testing. Typically, these devices can diagnose obstructive sleep apnea and hence contribute significantly to the home sleep apnea test devices market.
Restraint: High initial investment and market fragmentation
In the home sleep apnea test devices market, the high initial investment required for the development and installation of these devices, especially for large-scale projects, can be a significant barrier to market growth. Additionally, companies must continuously innovate and adapt to changing preferences in order to retain and attract customers.
The home sleep apnea test devices market is fragmented, with many companies offering similar products and services. This makes it challenging to stand out and gain market share in such a competitive environment. Meeting the changing expectations of customers in terms of product quality, service, and experience is also a challenge.
Opportunity: The rising adoption of advanced sleep apnea devices
The shift in patient preferences from traditional sleep apnea devices to technologically advanced options is driving the growth of the sleep apnea devices market. Many patients now prefer mandibular advancement devices (MAD) over continuous positive airway pressure (CPAP) for treating obstructive sleep apnea. This change in preference is due to the discomfort and complications often associated with CPAP. The adoption of CPAP has significantly decreased in recent years with the introduction of alternatives like oral appliances. These factors are expected to have a positive impact on the global home sleep apnea test devices market during the forecast period.
The type 3 segment dominated the home sleep apnea test devices market in 2023. Type 3 devices are more cost-effective compared to polysomnography (PSG) devices, offering high effectiveness and efficiency in diagnosing obstructive sleep apnea. Furthermore, Type 3 devices have multiple functions, including detecting ECG or heart rate, oxygen saturation, and channels of respiratory movement and airflow. The increased production of Type 3 devices is subsequently driving market growth.
The home sleep apnea test devices market is expected to see the fastest growth in the type 4 segment. Type 4 devices, also known as portable cardio-respiratory monitors or home sleep apnea tests (HSAT), are used for screening obstructive sleep apnea (OSA) or aiding in diagnosing OSA in patients with a high pretest probability of moderate to severe OSA. Various HSAT devices have been developed for clinical use. One notable Type 4 HSAT device, developed in Japan, is widely used and highly popular. While some data indicate the usefulness of the Apnomonitor® for OSA screening, the clinical utility of its latest version, the Apnomonitor Mini®, has not been verified.
Segments Covered in the Report
By Test Type
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Home Sleep Apnea Testing Devices Market
5.1. COVID-19 Landscape: Home Sleep Apnea Testing Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Home Sleep Apnea Testing Devices Market, By Test Type
8.1. Home Sleep Apnea Testing Devices Market Revenue and Volume, by Test Type, 2024-2033
8.1.1. Type 2
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Type 3
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Type 4
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Home Sleep Apnea Testing Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.1.2. U.S.
9.1.2.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.2.2. UK
9.2.2.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.2.3. Germany
9.2.3.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.2.4. France
9.2.4.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.3.2. India
9.3.2.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.3.3. China
9.3.3.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.3.4. Japan
9.3.4.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.4.2. GCC
9.4.2.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.4.3. North Africa
9.4.3.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.4.4. South Africa
9.4.4.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.5.2. Brazil
9.5.2.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Volume Forecast, by Test Type (2021-2033)
Chapter 10. Company Profiles
10.1. Fisher & Paykel Healthcare
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. ImThera Medical, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Natus Medical, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Somnetics International, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Braebon Medical Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. BMC Medical Co., Ltd.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Teleflex, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Weinmann Medical Devices GmbH & Co., KG.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Philips Respironics
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. CareFusion Corp.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client